secwatch.observer — SEC 8-K summary
======================================

Issuer:     Processa Pharmaceuticals, Inc. (PCSA)
CIK:        0001533743
Form:       8-K
Filed at:   2023-06-29T23:59:59+00:00
Accession:  0001493152-23-022920
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.03, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Processa increases authorized common shares to 100M; all director nominees elected at annual meeting
--------------------------------------------------------------------------------

- Shareholders approved amendment to increase authorized common stock from 50M to 100M shares.
- All six director nominees (Yorke, Young, Baluch, Neal, Pannu, Thompson) elected with >9.8M votes each.
- Ratification of BD & Company as independent auditor for FY 2023 approved with 12.86M for.
- Advisory vote on executive compensation passed with 9.72M for, 1.92M against.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1533743/000149315223022920/0001493152-23-022920-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1533743/000149315223022920/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-022920

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer